{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:51:48Z","timestamp":1791438708130,"version":"4.3.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004286","name":"Santen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s40123-026-01411-3","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:50:54Z","timestamp":1781250654000},"page":"2413-2429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Evolution of Treatment Outcomes with Once-Daily Ciclosporin A 0.1% Cationic Emulsion in Patients with Dry Eye Disease and Severe Keratitis"],"prefix":"10.1007","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct04144413","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7246-8580","authenticated-orcid":false,"given":"Andrea","family":"Leonardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Aragona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite","family":"Sainz de la Maza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei","family":"Seleznev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Wylegala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Study Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Liehneova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Korda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Nekolova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Masek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Cech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rybarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatana","family":"Laboha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fogagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Barabino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Viola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Siewierska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Zarnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Mrukwa-Kominek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Fryczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Misiuk-Hojlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Astakhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Gavrilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Gornostaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei","family":"Seleznev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda","family":"Pozdeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo Ruiz","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Peris-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mendicute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Pinilla","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Lamarca","family":"Mateu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omur","family":"Gunduz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melis","family":"Palamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"1411_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ajo.2025.05.040","volume":"279","author":"F Stapleton","year":"2025","unstructured":"Stapleton F, Arg\u00fceso P, Asbell P, Azar D, Bosworth C, Chen W, et\u00a0al. TFOS DEWS III: digest. Am J Ophthalmol. 2025;279:451\u2013553. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.040.","journal-title":"Am J Ophthalmol"},{"key":"1411_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ajo.2025.05.033","volume":"279","author":"JS Wolffsohn","year":"2025","unstructured":"Wolffsohn JS, Ben\u00edtez-Del-Castillo JM, Loya-Garcia D, Inomata T, Iyer G, Liang L, et\u00a0al. TFOS DEWS III: diagnostic methodology. Am J Ophthalmol. 2025;279:387\u2013450. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.033.","journal-title":"Am J Ophthalmol"},{"key":"1411_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/aos.13436","volume":"96","author":"C Baudouin","year":"2018","unstructured":"Baudouin C, Irke\u00e7 M, Messmer EM, Ben\u00edtez-Del-Castillo JM, Bonini S, Figueiredo FC, et\u00a0al. Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting. Acta Ophthalmol. 2018;96:111\u20139. https:\/\/doi.org\/10.1111\/aos.13436.","journal-title":"Acta Ophthalmol"},{"key":"1411_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jtos.2021.10.007","volume":"23","author":"MK Morthen","year":"2022","unstructured":"Morthen MK, Magno MS, Utheim TP, Snieder H, Jansonius N, Hammond CJ, et\u00a0al. The vision-related burden of dry eye. Ocul Surf. 2022;23:207\u201315. https:\/\/doi.org\/10.1016\/j.jtos.2021.10.007.","journal-title":"Ocul Surf"},{"key":"1411_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtos.2021.05.006","volume":"21","author":"MK Morthen","year":"2021","unstructured":"Morthen MK, Magno MS, Utheim TP, Snieder H, Hammond CJ, Vehof J. The physical and mental burden of dry eye disease: a large population-based study investigating the relationship with health-related quality of life and its determinants. Ocul Surf. 2021;21:107\u201317. https:\/\/doi.org\/10.1016\/j.jtos.2021.05.006.","journal-title":"Ocul Surf"},{"key":"1411_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","volume":"1","author":"M Uchino","year":"2013","unstructured":"Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep. 2013;1:51\u20137. https:\/\/doi.org\/10.1007\/s40135-013-0009-1.","journal-title":"Curr Ophthalmol Rep"},{"key":"1411_CR7","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640\u201350. https:\/\/doi.org\/10.1097\/00003226-200310000-00008.","journal-title":"Cornea"},{"key":"1411_CR8","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1080\/09273948.2022.2088566","volume":"31","author":"M Labetoulle","year":"2023","unstructured":"Labetoulle M, Leonardi A, Pisella PJ, Baudouin C. Ciclosporin A cationic emulsion 0.1% for the management of dry eye disease: facts that matter for eye-care providers. Ocul Immunol Inflamm. 2023;31:1707\u201315. https:\/\/doi.org\/10.1080\/09273948.2022.2088566.","journal-title":"Ocul Immunol Inflamm"},{"key":"1411_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21239271","volume":"21","author":"K Tsubota","year":"2020","unstructured":"Tsubota K, Pflugfelder SC, Liu Z, Baudouin C, Kim HM, Messmer EM, et\u00a0al. Defining dry eye from a clinical perspective. Int J Mol Sci. 2020;21:1\u201324. https:\/\/doi.org\/10.3390\/ijms21239271.","journal-title":"Int J Mol Sci"},{"key":"1411_CR10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1055\/a-1115-4756","volume":"237","author":"U Pleyer","year":"2020","unstructured":"Pleyer U, Geerling G, Schrader S, Jacobi C, Kimmich F, Messmer E. If artificial tears aren\u2019t enough the importance of inflammatory processes in dry eye disease. Practical aspects of an anti-inflammatory therapy of dry eye disease. Klin Monbl Augenheilkd. 2020;237:655\u201368. https:\/\/doi.org\/10.1055\/a-1115-4756.","journal-title":"Klin Monbl Augenheilkd"},{"key":"1411_CR11","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1177\/11206721221141481","volume":"33","author":"EM Messmer","year":"2023","unstructured":"Messmer EM, Ahmad S, Benitez del Castillo JM, Mrukwa-Kominek E, Rolando M, Vitovska O, et\u00a0al. Management of inflammation in dry eye disease: recommendations from a European panel of experts. Eur J Ophthalmol. 2023;33:1294\u2013307. https:\/\/doi.org\/10.1177\/11206721221141481.","journal-title":"Eur J Ophthalmol"},{"key":"1411_CR12","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.ophtha.2015.02.037","volume":"122","author":"F Amparo","year":"2015","unstructured":"Amparo F, Schaumberg DA, Dana R. Comparison of two questionnaires for dry eye symptom assessment: the Ocular Surface Disease Index and the Symptom Assessment in Dry Eye. Ophthalmology. 2015;122:1498\u2013503. https:\/\/doi.org\/10.1016\/j.ophtha.2015.02.037.","journal-title":"Ophthalmology"},{"key":"1411_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/life13091941","author":"R Martin","year":"2023","unstructured":"Martin R, Emo Research Group. Comparison of the Ocular Surface Disease Index and the Symptom Assessment in Dry Eye questionnaires for dry eye symptom assessment. Life Basel. 2023. https:\/\/doi.org\/10.3390\/life13091941.","journal-title":"Life Basel"},{"key":"1411_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1001\/jamaophthalmol.2013.4503","volume":"131","author":"Y Sakane","year":"2013","unstructured":"Sakane Y, Yamaguchi M, Yokoi N, Uchino M, Dogru M, Oishi T, et\u00a0al. Development and validation of the dry eye-related quality-of-life score questionnaire. JAMA Ophthalmol. 2013;131:1331\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.4503.","journal-title":"JAMA Ophthalmol"},{"key":"1411_CR15","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","volume":"23","author":"KK Nichols","year":"2004","unstructured":"Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762\u201370. https:\/\/doi.org\/10.1097\/01.ico.0000133997.07144.9e.","journal-title":"Cornea"},{"key":"1411_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1080\/09286586.2023.2248629","volume":"31","author":"A Tawfik","year":"2024","unstructured":"Tawfik A, Pistilli M, Maguire MG, Chen Y, Yu Y, Greiner JV, et\u00a0al. Association of dry eye symptoms and signs in patients with dry eye disease. Ophthalmic Epidemiol. 2024;31:274\u201382. https:\/\/doi.org\/10.1080\/09286586.2023.2248629.","journal-title":"Ophthalmic Epidemiol"},{"key":"1411_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.joco.2018.05.002","volume":"30","author":"S Kyei","year":"2018","unstructured":"Kyei S, Dzasimatu SK, Asiedu K, Ayerakwah PA. Association between dry eye symptoms and signs. J Curr Ophthalmol. 2018;30:321\u20135. https:\/\/doi.org\/10.1016\/j.joco.2018.05.002.","journal-title":"J Curr Ophthalmol"},{"key":"1411_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/J.OPHTHA.2016.11.008","volume":"124","author":"J Vehof","year":"2017","unstructured":"Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, Hammond CJ. Predictors of discordance between symptoms and signs in dry eye disease. Ophthalmology. 2017;124:280\u20136. https:\/\/doi.org\/10.1016\/J.OPHTHA.2016.11.008.","journal-title":"Ophthalmology"},{"key":"1411_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2024.102248","author":"M Hoffmann","year":"2024","unstructured":"Hoffmann M, Farrell S, Colorado LH, Edwards K. Discordant dry eye disease and chronic pain: a systematic review and meta-analysis. Cont Lens Anterior Eye. 2024. https:\/\/doi.org\/10.1016\/j.clae.2024.102248.","journal-title":"Cont Lens Anterior Eye"},{"key":"1411_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106206","author":"HB Mohamed","year":"2022","unstructured":"Mohamed HB, Abd El-Hamid BN, Fathalla D, Fouad EA. Current trends in pharmaceutical treatment of dry eye disease: a review. Eur J Pharm Sci. 2022. https:\/\/doi.org\/10.1016\/j.ejps.2022.106206.","journal-title":"Eur J Pharm Sci"},{"key":"1411_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajo.2025.05.039","volume":"279","author":"L Jones","year":"2025","unstructured":"Jones L, Craig JP, Markoulli M, Karpecki P, Akpek EK, Basu S, et\u00a0al. TFOS DEWS III: management and therapy. Am J Ophthalmol. 2025;279:289\u2013386. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.039.","journal-title":"Am J Ophthalmol"},{"key":"1411_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.5301\/ejo.5000779","volume":"26","author":"A Leonardi","year":"2016","unstructured":"Leonardi A, Van Setten G, Amrane M, Ismail D, Garrigue JS, Figueiredo FC, et\u00a0al. Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial. Eur J Ophthalmol. 2016;26:287\u201396. https:\/\/doi.org\/10.5301\/ejo.5000779.","journal-title":"Eur J Ophthalmol"},{"key":"1411_CR23","doi-asserted-by":"publisher","first-page":"520","DOI":"10.5301\/EJO.5000952","volume":"27","author":"C Baudouin","year":"2017","unstructured":"Baudouin C, Figueiredo FC, Messmer EM, Ismail D, Amrane M, Garrigue JS, et\u00a0al. A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye. Eur J Ophthalmol. 2017;27:520\u201330. https:\/\/doi.org\/10.5301\/EJO.5000952.","journal-title":"Eur J Ophthalmol"},{"key":"1411_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.5301\/ejo.5001002","volume":"27","author":"C Baudouin","year":"2017","unstructured":"Baudouin C, De La Maza MS, Amrane M, Garrigue JS, Ismail D, Figueiredo FC, et\u00a0al. One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease. Eur J Ophthalmol. 2017;27:678\u201385. https:\/\/doi.org\/10.5301\/ejo.5001002.","journal-title":"Eur J Ophthalmol"},{"key":"1411_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/bjophthalmol-2017-311801","volume":"103","author":"A Leonardi","year":"2019","unstructured":"Leonardi A, Messmer EM, Labetoulle M, Amrane M, Garrigue JS, Ismail D, et\u00a0al. Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies. Br J Ophthalmol. 2019;103:125\u201331. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311801.","journal-title":"Br J Ophthalmol"},{"key":"1411_CR26","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s40123-022-00487-x","volume":"11","author":"G Geerling","year":"2022","unstructured":"Geerling G, Hamada S, Trocm\u00e9 S, R\u00e6der S, Chen X, Fassari C, et\u00a0al. Real-world effectiveness, tolerability and safety of cyclosporine A 0.1% cationic emulsion in severe keratitis and dry eye treatment. Ophthalmol Ther. 2022;11:1101\u201317. https:\/\/doi.org\/10.1007\/s40123-022-00487-x.","journal-title":"Ophthalmol Ther"},{"key":"1411_CR27","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/bjophthalmol-2020-317907","volume":"106","author":"R Deshmukh","year":"2022","unstructured":"Deshmukh R, Ting DSJ, Elsahn A, Mohammed I, Said DG, Dua HS. Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases. Br J Ophthalmol. 2022;106:1087\u201392. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317907.","journal-title":"Br J Ophthalmol"},{"key":"1411_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41433-018-0289-7","volume":"33","author":"J Hind","year":"2019","unstructured":"Hind J, Macdonald E, Lockington D. Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease. Eye. 2019;33:685\u20136. https:\/\/doi.org\/10.1038\/s41433-018-0289-7.","journal-title":"Eye"},{"key":"1411_CR29","unstructured":"Santen Oy F. Ikervis (ciclosporin A) 1 mg\/ml. Summary of product characteristics. 2023. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ikervis-epar-product-information_en.pdf. Accessed 22 Apr 2024."},{"key":"1411_CR30","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.clinthera.2018.09.012","volume":"40","author":"M Labetoulle","year":"2018","unstructured":"Labetoulle M, Leonardi A, Amrane M, Ismail D, Garrigue J-S, Garh\u00f6fer G, et\u00a0al. Persistence of efficacy of 0.1% cyclosporin a cationic emulsion in subjects with severe keratitis due to dry eye disease: a nonrandomized, open-label extension of the SANSIKA study. Clin Ther. 2018;40:1894\u2013906. https:\/\/doi.org\/10.1016\/j.clinthera.2018.09.012.","journal-title":"Clin Ther"},{"key":"1411_CR31","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.2147\/OPTH.S184412","volume":"13","author":"RC de Oliveira","year":"2019","unstructured":"de Oliveira RC, Wilson SE. Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease. Clin Ophthalmol. 2019;13:1115\u201322. https:\/\/doi.org\/10.2147\/OPTH.S184412.","journal-title":"Clin Ophthalmol"},{"key":"1411_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076121","volume":"8","author":"DA Schaumberg","year":"2013","unstructured":"Schaumberg DA, Uchino M, Christen WG, Semba RD, Buring JE, Li JZ. Patient reported differences in dry eye disease between men and women: impact, management, and patient satisfaction. PLoS ONE. 2013;8:e76121. https:\/\/doi.org\/10.1371\/journal.pone.0076121.","journal-title":"PLoS ONE"},{"key":"1411_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ajo.2006.02.038","volume":"142","author":"A Gulati","year":"2006","unstructured":"Gulati A, Sullivan R, Buring JE, Sullivan DA, Dana R, Schaumberg DA. Validation and repeatability of a short questionnaire for dry eye syndrome. Am J Ophthalmol. 2006;142:125\u201331. https:\/\/doi.org\/10.1016\/j.ajo.2006.02.038.","journal-title":"Am J Ophthalmol"},{"key":"1411_CR34","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126:1763\u20138. https:\/\/doi.org\/10.1213\/ANE.0000000000002864.","journal-title":"Anesth Analg"},{"key":"1411_CR35","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1136\/bjophthalmol-2013-304728","volume":"98","author":"P Aragona","year":"2014","unstructured":"Aragona P. Topical cyclosporine: are all indications justified? Br J Ophthalmol. 2014;98:1001\u20132. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-304728.","journal-title":"Br J Ophthalmol"},{"key":"1411_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","volume":"4","author":"C Baudouin","year":"2013","unstructured":"Baudouin C, Aragona P, Messmer EM, Tomlinson A, Calonge M, Boboridis KG, et\u00a0al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf. 2013;4:246\u201358.","journal-title":"Ocul Surf"},{"key":"1411_CR37","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/jop.2020.0011","volume":"36","author":"P Daull","year":"2020","unstructured":"Daull P, Amrane M, Ismail D, Georgiev G, Cwiklik L, Baudouin C, et\u00a0al. Cationic emulsion-based artificial tears as a mimic of functional healthy tear film for restoration of ocular surface homeostasis in dry eye disease. J Ocul Pharmacol Ther. 2020;36:355\u201365. https:\/\/doi.org\/10.1089\/jop.2020.0011.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1411_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052434","author":"M Labetoulle","year":"2022","unstructured":"Labetoulle M, Benitez-Del-Castillo JM, Barabino S, Herrero Vanrell R, Daull P, Garrigue J-S, et\u00a0al. Artificial tears: biological role of their ingredients in the management of dry eye disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23052434.","journal-title":"Int J Mol Sci"}],"updated-by":[{"DOI":"10.1007\/s40123-026-01512-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000}}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01411-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01411-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01411-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:08:15Z","timestamp":1791436095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01411-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1411"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01411-3","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to author name \"Banu Bozkurt\" and authors affiliations are incorrectly incorporated in the acknowledgment section. Now, it have been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40123-026-01512-z","URL":"https:\/\/doi.org\/10.1007\/s40123-026-01512-z","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Andrea Leonardi is a consultant for or has received speaker fees from AstraZeneca, Bausch & Lomb, Domp\u00e8, FAES Farma, FIDIA, Novartis, Santen Pharmaceutical Co. Ltd., Laboratoires Th\u00e9a, and SIFI. Pasquale Aragona received honoraria from Abbvie, Alcon, Bausch & Lomb, FB Vision, Fidia, Medivis, Santen, Sifi, Sun Pharma, Tarsus, Thea, and TRB Chemedica for participating in advisory boards, educational events, focus groups and\/or expert panels, and scientific research support given to his department. Maite Sainz de la Maza received honoraria from Santen, Thea, Bausch & Lomb, NTC, Sanofi, and Novartis for participating in advisory boards, educational events, focus groups,and\/or expert panels, and scientific research support. Aleksei Seleznev received honoraria from Sentiss Rus, Santen, Thea, NTC, Novartis, AbbVie, and Viatris for participating in advisory boards, educational events, focus groups and\/or expert panels, and scientific research support. Edward Wylegala is a consultant for Bausch & Lomb, Santen, Fidia, and Th\u00e9a. Edoardo Villani has received honoraria from AbbVie, Alcon, Bausch & Lomb, Diadema, Essilor Luxottica, FB Vision, Fidia, Santen, Sifi, Thea, Unifarco, and Visufarma for contributing to advisory boards, educational events, and focus groups and\/or expert panels. Christophe Baudouin is a consultant for Bausch & Lomb, Horus Pharma, Oculis, Santen, Glaukos, and Th\u00e9a.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed after independent ethics committee (IEC) approval. The protocol and amendments were reviewed and approved by the relevant IECs for each study site. Participating patients were required to give written informed consent. The study was conducted in accordance with the Declaration of Helsinki and its most recent update and the International Council for Harmonisation (ICH) E6 Good Clinical Practice (GCP) guideline.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}